Dermal Fillers Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Absorbable Dermal Fillers and Non-absorbable Dermal Fillers), By Ingredient Type (Hyaluronic Acid (HLA), Poly-L-Lactic Acid (PLA), Calcium Hydroxylapatite (CaH), Polymethylmethacrylate (PMMA)), Polycaprolactone (PCL)), By End User (Aesthetic Hospitals, Cosmetic Clinics, Others) and Region Forecast 2019-2030  

Dermal Fillers Market size is expected to grow from US$ 3,416.0 million in 2023 to US$ 7,255.3 million by 2030 at a CAGR of 10% during 2024-2030. Dermal fillers are injectable treatments that can help to diminish the appearance of wrinkles while restoring volume and fullness in the face and hands or to reshape features to meet aesthetic goals, such as achieving a fuller lip or correcting the appearance of a recessed chin.

The market is primarily driven by the growing demand for minimally invasive aesthetic procedures, the increasing geriatric population, increasing awareness about cosmetic treatments, rise in beauty consciousness, and technological advancements in filler products. For instance, according to WHO, in 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. Between 2020 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. However, potential side effects, stringent regulatory approvals, and high costs associated with dermal fillers may pose challenges to market growth.

Furthermore, current breakthroughs such as HA filler for subtle lip enhancement that improves lip definition without increasing lip size will encourage a greater desire for dermal filler procedures. In recent years, both industrialized and developing countries have seen a considerable increase in facilities such as clinics, medical spas, and rejuvenation centers. As a result, the business will increase due to the fast adoption of various non-invasive therapies given by these facilities, which have advantages such as cost-effectiveness and shorter treatment times. A growing number of competent specialists, such as dermatologists and plastic surgeons, will also contribute to the industry's growth. Several players in the dermal fillers market are actively updating their research and development activities to come out with unique products and new launches. This factor will result in more revenues, eventually boosting the dermal fillers market's growth rate.

Dermal Fillers Market Key Developments

• In February 2024, Merz Aesthetics receives EU approval for the new indication for Radiesse® as an aesthetic injectable to improve moderate and severe wrinkles in the décolleté area.
• In May 2024, JUVÉDERM® VOLUMA® XC receives U.S. FDA approval for temple hollows. JUVÉDERM® VOLUMA® XC is the first and only hyaluronic acid (HA) dermal filler to receive U.S. FDA approval for improving moderate to severe temple hollowing with results lasting up to 13 months with optimal treatment.
• In September 2021, Suneva Medical announced that it had raised US$ 15 million in the financing, which will be used to pay down existing debt and assist its growth and expansion as the leader in regenerative aesthetics.
• In August 2020, Revance launched the RHA Collection of dermal fillers, Resilient Hyaluronic Acid, and the HintMD financial technology platform in the United States in September. This will strengthen the company's footprint in the United States and raise demand for RHA products.